GTX-VAX Trademark

Trademark Overview


On Saturday, November 25, 2023, a trademark application was filed for GTX-VAX with the United States Patent and Trademark Office. The USPTO has given the GTX-VAX trademark a serial number of 98284707. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, November 5, 2024. This trademark is owned by DNAGTX IP HOLDINGS INC.. The GTX-VAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of personalized cancer vaccines
gtx-vax

General Information


Serial Number98284707
Word MarkGTX-VAX
Filing DateSaturday, November 25, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development of personalized cancer vaccines

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 25, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDNAGTX IP HOLDINGS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDr. Gainesville, VA 20155

Trademark Events


Event DateEvent Description
Saturday, November 25, 2023NEW APPLICATION ENTERED
Tuesday, February 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 25, 2024ASSIGNED TO EXAMINER
Wednesday, June 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 26, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 5, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, November 5, 2024FINAL REFUSAL WRITTEN
Tuesday, November 5, 2024FINAL REFUSAL E-MAILED